07 diciembre 2009

ASH : Results of a cost analysis that compared multiple myeloma treatments found that treatment with bortezomib (Velcade) ...

... was associated with less out-of-pocket expenses than was treatment with the oral medications lenolidomide (Revlimid) and thalidomide (Thalomid).

...